Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjögren's syndrome

Por Hartkamp, A, Geenen, R, Bijl, M, Kruize, A, Godaert, G, Derksen, R
Publicado em 2004

Central nervous system mechanisms in Sjögren’s syndrome

Por van Bijsterveld, O P, Kruize, A A, Bleys, R L A W
Publicado em 2003

Sjögren's syndrome in patients with chronic idiopathic axonal polyneuropathy

Por van Dijk, G W, Notermans, N, Kater, L, Kruize, A, Linssen, W, Wokke, J
Publicado em 1997

Arthritis in hyperimmunoglobulinaemia D.

Por Loeliger, A E, Kruize, A A, Bijilsma, J W, Loeliger, A E, Derksen, R H
Publicado em 1993

Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.

Por van der Veen, M J, van der Heide, A, Kruize, A A, Bijlsma, J W
Publicado em 1994

High dose cyclophosphamide followed by autologous stem cell transplantation for the treatment of intractable rheumatoid arthritis (RA): a 2-year clinical and immunological follow-u...

Por Verburg, RJ, Sont, JK, Kruize, A, van den Hoogen, F, Breedveld, FC, van Laar, JM
Publicado em 2002

Long term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren's syndrome

Por Kruize, A, van Bijsterveld, O P, Hene, R, de Wilde, P C M, Feltkamp, T, Kater, L, Bijlsma, J
Publicado em 1997

Determinants of direct costs in Dutch rheumatoid arthritis patients

Por Verstappen, S, Verkleij, H, Bijlsma, J, Buskens, E, Kruize, A, Heurkens, A, van der Veen, M J, Jacobs, J
Publicado em 2004

Sjögren's syndrome in patients with chronic idiopathic axonal polyneuropathy

Por DENISLIC, M., MEH, D., VAN DIJK, G W, NOTERMANS, N, WOKKE, J, KATER, L, KRUIZE, A, LINSSEN, W
Publicado em 1998

Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.

Por Kruize, A A, Hené, R J, Kallenberg, C G, van Bijsterveld, O P, van der Heide, A, Kater, L, Bijlsma, J W
Publicado em 1993

Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome

Por van Woerkom, J M, Kruize, A, Wenting, -, Knol, E, Bihari, I, Jacobs, J, Bijlsma, J, Lafeber, F, van Roon, J A G
Publicado em 2005

Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study

Por van Woerkom, J M, Kruize, A A, Geenen, R, van Roon, E N, Goldschmeding, R, Verstappen, S M M, van Roon, J A G, Bijlsma, J W J
Publicado em 2007

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial

Por van Jaarsveld, C H M, Jacobs, J, van der Veen, M J, Blaauw, A, Kruize, A, Hofman, D, Brus, H, van Albada-Kuiper..., G A, Heurkens, A, ter Borg, E J, Haanen, H, van Booma-Frankfo..., C, Schenk, Y, Bijlsma, J
Publicado em 2000